Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $18.8333.

A number of analysts have weighed in on the company. Zacks Research upgraded Alignment Healthcare to a “hold” rating in a research note on Friday, August 8th. Stephens upgraded shares of Alignment Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Barclays upgraded shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $9.00 to $13.00 in a report on Thursday, July 31st. KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective for the company in a research report on Monday, August 25th. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $15.86 on Friday. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market capitalization of $3.14 billion, a P/E ratio of -56.64 and a beta of 1.17. Alignment Healthcare has a 1-year low of $8.65 and a 1-year high of $21.06. The company’s 50-day moving average is $14.18 and its 200 day moving average is $15.42.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $960.25 million. During the same quarter in the prior year, the firm posted ($0.13) earnings per share. The company’s quarterly revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts forecast that Alignment Healthcare will post -0.69 EPS for the current year.

Insider Buying and Selling

In other news, Director Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $16.00, for a total transaction of $400,000.00. Following the transaction, the director owned 1,152,049 shares of the company’s stock, valued at approximately $18,432,784. This represents a 2.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO John E. Kao sold 180,000 shares of the firm’s stock in a transaction on Thursday, July 10th. The shares were sold at an average price of $13.41, for a total value of $2,413,800.00. Following the transaction, the chief executive officer owned 1,553,100 shares in the company, valued at approximately $20,827,071. This represents a 10.39% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 636,185 shares of company stock valued at $9,235,468 over the last 90 days. 7.00% of the stock is owned by insiders.

Institutional Trading of Alignment Healthcare

A number of hedge funds have recently added to or reduced their stakes in the business. MCF Advisors LLC boosted its position in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after acquiring an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Alignment Healthcare during the 1st quarter worth $42,000. SBI Securities Co. Ltd. boosted its position in Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after purchasing an additional 2,970 shares in the last quarter. KBC Group NV bought a new stake in Alignment Healthcare during the second quarter valued at about $44,000. Finally, Signaturefd LLC grew its stake in Alignment Healthcare by 142.6% in the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after purchasing an additional 2,215 shares during the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.